DENVER, March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) has announced that its CFO, Joel Ackerman, and group VP of investor relations, Nic Eliason, will take part in a fireside chat with investors at the Barclays Global Healthcare Conference 2025 on Tuesday, March 11, 2025, at 9:00 a.m. EDT. You can watch the live webcast by visiting the Barclays website and registering for free.
On February 14, Davita Inc. (NYSE: DVA) saw its shares drop by 11% after the dialysis company announced a 2025 earnings forecast that was lower than anticipated. This decline was attributed to increasing costs for patient care, supply shortages, and the continued closure of dialysis centers.
DaVita Inc (DVA -11.09%) saw its shares drop on Friday. By the end of the trading day, the stock had fallen by 11.1%, although it had decreased by as much as 15.2% at one point during the day.
DaVita's stock dropped by 13.5% on Friday, making it the biggest loser in the S&P 500. This decline followed the news that Warren Buffett's Berkshire Hathaway reduced its investment in the kidney dialysis company.
Warren Buffett, known as the 'Oracle of Omaha', has built a net worth of about $142 billion by consistently beating the market. The CEO and chairman of Berkshire Hathaway (NYSE: BRK.B) achieved this through a thoughtful and calm investment strategy.
DaVita's stock fell after they provided a disappointing forecast due to increasing care expenses, and major investor Berkshire sold some of its shares as part of a pre-arranged plan.
DaVita Inc. (NYSE:DVA) will hold its Q4 2024 Earnings Conference Call on February 13, 2025, at 5:00 PM ET. The call will feature company representatives including Nic Eliason, Javier Rodriguez, and Joel Ackerman, along with participants from various financial institutions. The operator, Michelle, will guide the conference.
On Thursday evening, Berkshire Hathaway announced that it had sold 203,091 shares of DaVita. This sale decreased its ownership in the kidney dialysis company to approximately 35.89 million shares, which represents a 45% stake valued at nearly $6.4 billion.
DaVita HealthCare (DVA) reported quarterly earnings of $2.24 per share, which is higher than the Zacks Consensus Estimate of $2.21 per share. This is an increase compared to last year's earnings of $1.87 per share.
On Thursday, dialysis company DaVita announced that its expected annual profit would be lower than anticipated because of increasing patient care expenses, causing its stock to drop by 11% in after-hours trading.